Upon completion of the video presentation, to finish the activity and claim your credit, please click here.

This activity is supported by independent educational grants from AstraZeneca, Pfizer, and Takeda Oncology.

Advances in the Use of Targeted Therapies in the Management of Non–Small Cell Lung Cancer

Heather Wakelee, MD
Stanford Health Care

Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC
The University of Texas MD Anderson Cancer Center

Learn about the recent updates in the world of genetic testing and targeted therapies for non–small cell lung cancer. It’s vital that advanced practitioners in oncology have the latest knowledge on EGFR, ALK, and BRAF inhibitors, as well as acquired resistance mutations, to help patients from diagnosis through treatment.



 

Download Podcast

   To claim credit for podcast click here
 
 

Download Transcript

 
 

Download Slides

 
 

Download Slides & Transcripts

   To claim credit for the slides & transcript click here





These CME/CE/CPE accredited activities are jointly provided by

JADPRO CE Logo Harborside Press Logo APSHO Logo Annenberg Logo
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here